Globus Medical, Inc. (GMED) is a Medical - Devices company in the Healthcare sector, currently trading at $94.94. It has a SharesGrow Score of 81/100, indicating a strong investment profile with 5 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of GMED = $154.80 (+63.1% from the current price, the stock appears undervalued). Analyst consensus target is GMED = $104 (+9.5% upside).
Valuation: GMED trades at a trailing Price-to-Earnings (P/E) of 22.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.1.
Financials: revenue is $2.9B, +43.5%/yr average growth. Net income is $538M, growing at +123.6%/yr. Net profit margin is 18.3% (healthy). Gross margin is 67.4% (-6.8 pp trend).
Balance sheet: total debt is $119M against $4.6B equity (Debt-to-Equity (D/E) ratio 0.03, conservative). Current ratio is 4.26 (strong liquidity). Debt-to-assets is 2.2%. Total assets: $5.3B.
Analyst outlook: 27 / 36 analysts rate GMED as buy (75%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 59/100 (Partial), Growth 100/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 65/100 (Partial), Future 73/100 (Pass), Income 70/100 (Pass).
